ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1935

Predictors of Early Mortality for Giant Cell Arteritis at the Time of Diagnosis

Eduardo Dourado1, Sofia Barreira2, Ana Rita Cruz-Machado3, Joana Martinho3, Diana Raimundo4, Luísa Brites5, Helena Assunção5, Vítor Teixeira6, Nikita Khmelinskii3, Carla Macieira3, José A. P. da Silva7, João Eurico Fonseca8 and Cristina Ponte3, 1Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Lisboa, Portugal, 2Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal, 3Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal, 4Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal, 5Rheumatology Department, Centro Hospitalar Universitário Coimbra, Coimbra, Portugal, 6Rheumatology Department, Centro Hospitalar Universitário do Algarve, Faro, Portugal, 79.Centro Hospitalar e Universitário Coimbra (Rheumatology Department), Coimbra, Portugal, Coimbra, Portugal, 8Instituto de Medicina Molecular, Faculdade Medicina Universidade de Lisboa and Centro Hospitalar Universitário Lisboa Norte., Lisboa, Portugal

Meeting: ACR Convergence 2020

Keywords: giant cell arteritis, Mortality

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster II

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: Giant cell arteritis (GCA) is the most common form of primary systemic vasculitis, typically affecting patients aged > 50 years. If left untreated, GCA can lead to permanent visual loss and other ischaemic complications. During the first two years of diagnosis, mortality is significantly higher in GCA than in the general population, with a significant contribution of infections to mortality in the first year of treatment. Identifying patients with a higher risk of mortality at the time of diagnosis could be crucial for prevention and tailored treatment; however, independent predictors of early mortality have never been reported in the literature.

Methods: Bicentric observational study using data from the Portuguese Register of Rheumatic Diseases (Reuma.pt). Patients with biopsy- or ultrasound-proven GCA were included. Early mortality was defined as death occurring in the first two years after diagnosis. Univariate analysis was performed using Chi-Square, Fischer’s Exact Test and Mann-Whitney Test, as appropriate. Multivariate analysis was
performed using binary logistic regression modelling. The linearity of the continuous variables with respect to the logit of the dependent variable was assessed via the Box-Tidwell procedure.

Results: The study included 133 patients with 85 (66.4%) females and a median age at diagnosis of 75.0 (interquartile range [IQR] 12.0) years. Fourteen (10.5%) deaths occurred during the first two years after diagnosis. Early mortality was significantly associated with: (i) cranial ischaemic event, anterior ischaemic optic neuropathy, permanent loss of vision and tongue claudication at disease presentation; (ii) older age, atrial fibrillation, chronic kidney disease, creatinine level and treatment with bisphosphonates at diagnosis; and (iii) treatment with anticoagulants before disease onset (Table 1).

The multivariate analysis included 124 patients (5 patients had missing information, 4 patients were outliers) with 81 (65.3%) females, a median age at diagnosis of 75.0 (IQR 12.0) years, and 10 (8.1%) deaths in the first two years of diagnosis. The logistic regression model was statistically significant, χ2 (7) = 42.0, p< 0.001. The model explained 66.9% (Nagelkerke R2) of the variance in early mortality and correctly classified 96.0% of all cases. Older age at diagnosis (OR 1.3/year, 95%CI: 1.0-1.6, p=0.032), tongue claudication at disease presentation (OR 2106.8, 95%CI: 4.2-1057334.5, p=0.016), previous treatment with anticoagulants (OR 42.1, 95%CI: 2.6-682.0, p=0.009) and treatment with bisphosphonates at diagnosis (OR 0.0, 95%CI: 0.0-0.4, p=0.019) were identified as independent predictors of early mortality and survival, respectively (Table 2).

Conclusion: In our cohort, older age at diagnosis, tongue claudication at disease presentation and previous treatment with anticoagulants were independent predictors of early mortality. On the other hand, treatment with bisphosphonates at diagnosis was an independent predictor of early survival. These findings are novel and require replication. However, they highlight the need for a disease management not only focused on clinical manifestations but also drug adverse effects and comorbidities.

Table 1 – Results of the univariate analysis testing the association between the outcome variable (early mortality) and predictor variables

Table 2 – Logistic regression predicting the likelihood of early mortality for GCA, based on age, sex, cranial ischaemic event, tongue claudication, chronic kidney disease and treatment with anticoagulants and bisphosphonates (at the time of diagnosis)


Disclosure: E. Dourado, None; S. Barreira, None; A. Cruz-Machado, None; J. Martinho, None; D. Raimundo, None; L. Brites, None; H. Assunção, None; V. Teixeira, None; N. Khmelinskii, None; C. Macieira, None; J. da Silva, MyFibromyalgia®, a webcompany delivering services to patients with Fibromyalgia, 9; J. Fonseca, None; C. Ponte, None.

To cite this abstract in AMA style:

Dourado E, Barreira S, Cruz-Machado A, Martinho J, Raimundo D, Brites L, Assunção H, Teixeira V, Khmelinskii N, Macieira C, da Silva J, Fonseca J, Ponte C. Predictors of Early Mortality for Giant Cell Arteritis at the Time of Diagnosis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/predictors-of-early-mortality-for-giant-cell-arteritis-at-the-time-of-diagnosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictors-of-early-mortality-for-giant-cell-arteritis-at-the-time-of-diagnosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology